Laparoscopic greater curvature gastric plication in the treatment of type 2 diabetes

Лапароскопическая пликация большой кривизны желудка в лечении сахарного диабета 2 типа
Akzhunus Orekeshova 1, Oral Ospanov 1
More Detail
1 Astana Medical University, Endosurgery, Astana, Kazakhstan
J CLIN MED KAZ, Volume 2, Issue 40, pp. 57-59. https://doi.org/10.23950/1812-2892-2016-2-57-59
OPEN ACCESS 3478 Views 2429 Downloads
Download Full Text (PDF)

ABSTRACT

The purpose of the study: to evaluate the efficacy of laparoscopic greater curvature gastric plication in the treatment of type 2 diabetes.
Methods. The study involved 32 patients suffering from type 2 diabetes and obesity on average 6.87 ± 1.9 years.
Results. Participants in a year lost an average weight of 25 kg. Fasting glucose levels dropped significantly within six months after the operation, which correlates with the trend in the weight loss during this period. The average HbA1c for the cohort gradually decreased during the study period from 9.8% to 5.6%. Much of this change occurred during the first six months. Diabetes Remission was achieved in 92% of patients. In patients with remission, hypoglycemic agents were canceled after 4-22 weeks after surgery.
Conclusions. Laparoscopic greater curvature gastric plication lowest altering the physiology of the gastrointestinal tract, lowers blood glucose levels in patients suffering from type 2 diabetes and obesity.
Keywords: laparoscopic gastric plication, diabetes, obesity

CITATION

Orekeshova A, Ospanov O. Laparoscopic greater curvature gastric plication in the treatment of type 2 diabetes. Journal of Clinical Medicine of Kazakhstan. 2016;2(40):57-9. https://doi.org/10.23950/1812-2892-2016-2-57-59

REFERENCES

  • Haslam DW, James WPT. Obesity, Lancet, 2005. Vol. 366, No.9492, pp. 1197 - 1209.
  • Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity, J. Clin. Epidemiol, 1991, Vol. 44, No. 6, pp. 545 - 550.
  • Grundy SM, Cleeman JI, Daniels SR. et al. Diagnosis and Management of the Metabolic Syndrome, Circulation, 2005, Vol. 112, pp.35 - 52.
  • Tretbar LL, Taylor TL, Sifers EC. Weight reduction. Gastric plication for morbid obesity, J Kans Med Soc, Vol.77, No.11, pp. 488 - 490.
  • Talebpour M, Motamedi SM, Talebpour A, Vahidi H. Twelve year experience of laparoscopic gastric plication in morbid obesity: development of the technique and patient outcomes, Ann Surg Innov Res, 2012, No.22, pp. 6 - 7.
  • Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects, N Engl J Med, 2012, No. 367, pp. 695-704. doi: 10.1056/NEJMoa1112082.
  • Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after RouxenY gastric bypass surgery. Obes Surg. 2010, No. 20 (9), pp.1245–1250. doi: 10.1007/s11695-010-0198-8.
  • Pories W., Dohm G. Full and Durable Remission of Type 2 Diabetes? Through Surgery, Surg. Obes. Relat. Dis., 2009, No. 5 (2), pp.285 - 88.
  • Jiménez A, Casamitjana R, Viaplana-Masclans J, Lacy A, Vidal J. GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care, 2013, No.36 (7), pp.2062 - 2069. doi: 0.2337/dc12- 1535.
  • Spector D, Shikora S. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus. Int J Clin Pract Suppl. 2010, No. 166, pp.53 - 8. doi: 10.1111/j.1742-1241.2009.02279.x.